Galantamine-ER for the treatment of mild-to-moderate Alzheimer’s disease
Ben SeltzerGeriatric Research, Education and Clinical Center, VA Boston Healthcare System, Department of Neurology, Harvard Medical School, Boston, MA, USAAbstract: An extended release form of the cholinesterase inhibitor (ChEI) drug galantamine (galantamine-ER) was developed, chiefly to increase ad...
Saved in:
| Main Author: | |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Dove Medical Press
2009
|
| Subjects: | |
| Online Access: | https://doaj.org/article/ec5eae3b2b564894b57d87d60ff67430 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|